ArticleInfection and drug resistance2025
The Role of
Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dual anti-pseudomonal and resistance-modulatory actions ofPharmaceutical biology · 2026Article
- Genetic Determinants Linked to MDR/XDR inPathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the association of the resistance of extensively drug-resistant/ pan-drug-resistant Methods: Twofold dilution was used to determine the minimum inhibitory concentration (MIC) of CZA against XDR/PDR-PA. Whole genome sequencing and bioinformatics analysis were used to determine the drug-resistant genes of each isolate. Pearson correlation coefficient and statistical analysis were used to assess the association of the resistance of XDR/PDR-PA to CZA and various class D β-lactamase genes. Results: ST244 was the predominant type (34/68, 50%) among the 68 XDR/PDR-PA strains. Subsequently, ST357 was the second most prevalent type (5/68, 7.4%) strain. Conclusion: Our work found that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.